Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.

GB Sciences will soon start human testing of three cannabis-derived formulations for Parkinson's, chronic pain and cardiovascular diseases.

SynteractHCR has hired Steve Powell, who has years of experience on electronic data as a senior executive at Exco InTouch and PRA Health Sciences.

Medidata is making new conquests in the clinical trial world, as it just inked a deal to manage site payments for Worldwide Clinical Trials.

Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.

Science Exchange will offer IndieBio-backed biotech startups access to its outsourced R&D platform.

The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up plans to speed up the drug regulation process.

Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

Science Exchange has raised $28 million in its third funding round.

CRO